Acceleron

Here's Why Acceleron Pharma Inc. Lost 10.2% in July
Yahoo/Motley Fool
Sun, 08/5/18 - 07:17 pm
Acceleron
clinical trials
luspatercept
A 7-year-old alliance between Celgene and Acceleron is paying off with more promising PhIII data for luspatercept
Endpoints
Mon, 07/9/18 - 06:54 pm
Celgene
Acceleron
beta thalassemia
luspatercept
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Thu, 06/28/18 - 07:10 pm
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Motley Fool
Sun, 07/9/17 - 11:41 am
Celgene
Juno Therapeutics
Acceleron
Bluebird Bio
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Xtalks
Thu, 06/15/17 - 09:39 am
Acceleron
renal cell carcinoma
clinical trials
Axitinib
Ac­celeron dumps dalantercept after kidney cancer trial fail
Fierce Biotech
Tue, 06/13/17 - 11:57 am
Acceleron
dalantercept
kidney cancer
clinical trials
The Most Important Keys To Celgene's Pipeline
Seeking Alpha
Sat, 01/21/17 - 11:32 am
Celgene
Revlimid
Acceleron
Juno Therapeutics
Agios
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Yahoo
Sun, 12/6/15 - 10:16 am
Celgene
Acceleron
myelodysplastic syndromes
MDS
luspatercept
Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters
Seeking Alpha
Wed, 07/22/15 - 10:28 am
Acceleron
luspatercept
Celgene
dalantercept
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Mon, 05/18/15 - 11:16 am
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline
TheStreet.com
Thu, 10/2/14 - 10:54 am
Acceleron
Bluebird Bio
3 Biggest Biotech Crashes in March
Motley Fool
Fri, 04/4/14 - 09:29 am
Acceleron
Celldex Therapeutics
NewLink Genetics
[video]Biotech CEO looks down the pipeline for growth
CNBC
Fri, 03/28/14 - 08:19 am
Acceleron
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
TheStreet.com
Thu, 01/23/14 - 09:53 am
gene therapy
Biogen Idec
Sangamo BioSciences
Bluebird Bio
Acceleron
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Mon, 12/30/13 - 11:15 am
Amgen
Acceleron
Celgene
anemia
sotatercept
ACE-536
ASH Conference: 3 Companies To Watch
Seeking Alpha
Sun, 12/8/13 - 12:15 pm
Stemline Therapeutics
Portola
Acceleron
Acceleron: A Small Biotech Preparing To Supply Big Markets
Seeking Alpha
Mon, 09/23/13 - 09:47 am
Acceleron
Amgen
Celgene
IPOs
Acceleron Pharma - Successful Cancer Research IPO
Seeking Alpha
Sun, 09/22/13 - 11:35 am
Acceleron
[video]Biotech IPOs With Big Partners
TheStreet.com
Thu, 09/19/13 - 03:13 am
biotech
IPOs
Celgene
Amgen
Bind Therapeutics
Acceleron
Fate Therapeutics

Pages